It has been observed that the patients with tumor with methylated MGMT promoter have better survival rate when treated with combination therapy (radiation therapy along with chemotherapy with TMZ) as compared to those having unmethylated MGMT promoter tumor [38–40]. Here, MGMT is linked to neoplasm.